Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)

Nowadays, Major Depressive Disorder (MDD) has become a leading cause of disability in the world. Most patients suffering from depression are treated with serotonin reuptake inhibitors, but resistance has started emerging. Therefore, alternative treatments should be considered. Recent studies have sh...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Bilen, Maria (author)
التنسيق: masterThesis
منشور في: 2018
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/10725/8647
https://doi.org/10.26756/th.2018.98
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513485382090752
author Bilen, Maria
author_facet Bilen, Maria
author_role author
dc.creator.none.fl_str_mv Bilen, Maria
dc.date.none.fl_str_mv 2018-10-17T06:03:29Z
2018-10-17T06:03:29Z
2018
2018-10-17
2018-07-23
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/8647
https://doi.org/10.26756/th.2018.98
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Lebanese American University -- Dissertations
Dissertations, Academic
Methyl aspartate
Methionine -- Therapeutic use
Depression, Mental -- Animal models
Antidepressants
dc.title.none.fl_str_mv Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Nowadays, Major Depressive Disorder (MDD) has become a leading cause of disability in the world. Most patients suffering from depression are treated with serotonin reuptake inhibitors, but resistance has started emerging. Therefore, alternative treatments should be considered. Recent studies have shown that the brains of individuals affected with neuropsychiatric disorders have disrupted methylation patterns. Since methionine is the precursor of S-adenosylmethionine (SAM), a cofactor for most methyltransferases, the aim of the study was to examine the effect of methionine supplementation on chronic social defeat (CSD), the animal model of depression. Male C57BL/6 mice were subjected to CSD for 10 consecutive days, followed by behavioral testing to assess anxiety and depression-like symptoms. Animals subjected to CSD and treated with 1.55mg/Kg of methionine through intraperitoneal injections, showed a rescue in the social avoidance behavior. Molecular analysis of the cortices of these animals revealed that methionine treatment restored the expression levels of NMDA receptor subunits, Grin 1, Grin 2a and Grin 2b to baseline when compared to the increased levels observed in defeated animals treated with saline only. This increase was accompanied by a reduction in the protein levels of the histone methyltransferase known to modulate NMDA receptor expression, SetDB1 in defeated animals, while methionine injections returned SetDB1 levels to baseline. These findings suggest that methionine supplementation could serve as an antidepressant due to its role in modifying the histone methylation patterns and possibly regulating the NMDA gene expression.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_29331f93f7732d4184fc547d2acfcde8
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/8647
publishDate 2018
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)Bilen, MariaLebanese American University -- DissertationsDissertations, AcademicMethyl aspartateMethionine -- Therapeutic useDepression, Mental -- Animal modelsAntidepressantsNowadays, Major Depressive Disorder (MDD) has become a leading cause of disability in the world. Most patients suffering from depression are treated with serotonin reuptake inhibitors, but resistance has started emerging. Therefore, alternative treatments should be considered. Recent studies have shown that the brains of individuals affected with neuropsychiatric disorders have disrupted methylation patterns. Since methionine is the precursor of S-adenosylmethionine (SAM), a cofactor for most methyltransferases, the aim of the study was to examine the effect of methionine supplementation on chronic social defeat (CSD), the animal model of depression. Male C57BL/6 mice were subjected to CSD for 10 consecutive days, followed by behavioral testing to assess anxiety and depression-like symptoms. Animals subjected to CSD and treated with 1.55mg/Kg of methionine through intraperitoneal injections, showed a rescue in the social avoidance behavior. Molecular analysis of the cortices of these animals revealed that methionine treatment restored the expression levels of NMDA receptor subunits, Grin 1, Grin 2a and Grin 2b to baseline when compared to the increased levels observed in defeated animals treated with saline only. This increase was accompanied by a reduction in the protein levels of the histone methyltransferase known to modulate NMDA receptor expression, SetDB1 in defeated animals, while methionine injections returned SetDB1 levels to baseline. These findings suggest that methionine supplementation could serve as an antidepressant due to its role in modifying the histone methylation patterns and possibly regulating the NMDA gene expression.N/A1 hard copy: x, 45 leaves; ill.; 30 cm. available at RNL.Bibliography : leaves 39-45.Lebanese American University2018-10-17T06:03:29Z2018-10-17T06:03:29Z20182018-10-172018-07-23Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/8647https://doi.org/10.26756/th.2018.98http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.phpeninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/86472021-03-19T10:45:21Z
spellingShingle Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
Bilen, Maria
Lebanese American University -- Dissertations
Dissertations, Academic
Methyl aspartate
Methionine -- Therapeutic use
Depression, Mental -- Animal models
Antidepressants
status_str publishedVersion
title Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
title_full Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
title_fullStr Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
title_full_unstemmed Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
title_short Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
title_sort Methionine mediates resilience to chronic social defeat by modulating NMDA receptor expression in the cortex. (c2018)
topic Lebanese American University -- Dissertations
Dissertations, Academic
Methyl aspartate
Methionine -- Therapeutic use
Depression, Mental -- Animal models
Antidepressants
url http://hdl.handle.net/10725/8647
https://doi.org/10.26756/th.2018.98
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php